Pfizer Wins Approval For Tamper-Proof Pain Drug

Xconomy New York — 

The FDA has approved a new form of the opioid oxycodone, which was developed by New York-based Pfizer (NYSE: PFE) and Palatine, IL-based Acura Pharmaceuticals (NASDAQ: ACUR), according to a press release. The product, branded as Oxeta, applies technology developed by Acura that is designed to discourage common methods of tampering associated with opioid abuse.

By posting a comment, you agree to our terms and conditions.

Comments are closed.